Catalyst Pharm Inc (CPRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2016 | 09-2016 | 06-2016 | 03-2016 | 12-2015 | |
| Operating Expenses | 4,314 | 3,914 | 4,815 | 6,238 | 6,192 |
| Operating Income | -4,314 | -3,914 | -4,815 | -6,238 | -6,192 |
| Other Income | 151 | -40 | 246 | 851 | 377 |
| Pre-tax Income | -4,163 | -3,954 | -4,569 | -5,386 | -5,815 |
| Net Income Continuous | -4,163 | -3,954 | -4,569 | -5,386 | -5,815 |
| Net Income | $-4,163 | $-3,954 | $-4,569 | $-5,386 | $-5,815 |
| EPS Basic Total Ops | -0.04 | -0.05 | -0.06 | -0.07 | -0.07 |
| EPS Basic Continuous Ops | -0.05 | -0.05 | -0.06 | -0.07 | -0.07 |
| EPS Diluted Total Ops | -0.04 | -0.05 | -0.06 | -0.07 | -0.07 |
| EPS Diluted Continuous Ops | -0.05 | -0.05 | -0.06 | -0.07 | -0.07 |
| EBITDA(a) | $-4,302 | $-3,905 | $-4,806 | $-6,224 | $-6,186 |